TAM
KURA icon

Tiverton Asset Management’s Kura Oncology KURA Stock Holding History

Tiverton Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$112K Hold
7,394
– – ﹤0.01% 636
2019
Q2 		$146K Sell
7,394
-6,716
-48% -$111K 0.01% 587
2019
Q1 		$234K Hold
14,110
– – 0.01% 511
2018
Q4 		$198K Sell
14,110
-112,939
-89% -$1.5M 0.01% 308
2018
Q3 		$2.22M Buy
127,049
+6,716
+6% +$129K 0.11% 134
2018
Q2 		$2.19M Sell
120,333
-18,631
-13% -$316K 0.11% 130
2018
Q1 		$2.61M Buy
+138,964
New +$2.71M 0.18% 106

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Tiverton Asset Management's KURA Position: Q3 2019 in Review

Tiverton Asset Management held its Kura Oncology (KURA) position steady in Q3 2019 at 7,394 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

Tiverton Asset Management first reported a position in KURA in Q1 2018 and has held it in 7 quarters since. The position peaked at $2.61M in Q1 2018. 116 funds tracked by Wall St. Rank hold KURA as of Q3 2019.

  • Tiverton Asset Management held 7,394 shares of Kura Oncology worth $112K as of Q3 2019.
  • Tiverton Asset Management left its Kura Oncology share count unchanged in Q3 2019.
  • Kura Oncology made up ﹤0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #636 holding.
  • Tiverton Asset Management first reported a position in Kura Oncology in Q1 2018 and has held it in 7 quarters since.
  • Tiverton Asset Management's Kura Oncology position peaked at $2.61M in Q1 2018.
  • 116 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.